John R. Perkins II serves as Executive at Talecris Biotherapeutics Holdings Corp., where they oversee executive responsibilities. Since joining the company, John R. Perkins II has executed 10 insider transactions totaling $5.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 1, 2011 involved selling 26,820 shares valued at $0.
John R. Perkins II currently holds 26,820 shares of Talecris Biotherapeutics Holdings Corp. (TLCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John R. Perkins II has been a net seller of TLCR stock. They have purchased $0 and sold $5.5M worth of shares.
John R. Perkins II's most recent insider trade was on Jun 1, 2011, when they sold 26,820 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $26.94 |
| Discretionary |
| Apr 1, 2011 | TLCR | $0 | Award | 6,778 | $N/A | Discretionary |
| Sep 2, 2010 | TLCR | $490.8K | Option Exercise | 44,620 | $11.00 | Discretionary |
| Sep 2, 2010 | TLCR | $1.9M | Option Exercise | 168,704 | $11.00 | Discretionary |
| Sep 2, 2010 | V9SNS*IJ | $5.3M | Sale | 237,937 | $22.30 | Discretionary |
| Sep 1, 2010 | TLCR | $227.5K | Sale | 10,200 | $22.30 | Discretionary |
| Sep 1, 2010 | TLCR | $89.1K | Option Exercise | 8,100 | $11.00 | Discretionary |
| Mar 31, 2010 | TLCR | $143.4K | Payment | 7,199 | $19.92 | Discretionary |
| Sep 30, 2009 | TLCR | $0 | Award | 5,921 | $N/A | Discretionary |